This new therapy could cut “bad” cholesterol by half
In a new study, researchers found the experimental drug evinacumab reduced low-density lipoprotein (LDL) cholesterol—the so-called "bad" cholesterol—by 50% in people with a high...
This hormone may explain why women fare better men in COVID-19
Age is a well-known factor that influences the severity and fatality of COVID-19.
In addition, male and female patients are known, at least anecdotally, to...
Scientists find a possible way to prevent Alzheimer’s disease
In a new study, researchers found it might be possible to reduce the chances of developing Alzheimer's disease by editing a key gene in...
Why COVID-19 can cause deadly low oxygen level in the body
One of the biggest and most life-threatening mysteries in COVID-19 is how the virus causes "silent hypoxia," a condition when oxygen levels in the...
Many people recovered from COVID-19 still carry virus, study shows
Although meeting the criteria for discontinuation of quarantine, patients with persistent respiratory symptoms are more likely to test positive for the virus.
In a recent...
Two new anti-inflammatory drugs may boost recovery from COVID-19
In two new studies, researchers found that two anti-inflammatory compounds are capable of accelerating recovery from COVID-19.
They found the monoclonal antibody eculizumab and an...
Scientists find new way to effectively detect diabetes-related eye disease
In a new study, researchers created a novel deep learning method that makes automated screenings for eye diseases such as diabetic retinopathy more efficient.
Reducing...
People with severe flu do much better than those with COVID-19, study shows
In a new study, researchers showed how patients hospitalized with severe COVID-19 fared, compared to those hospitalized with severe seasonal influenza.
The study is believed...
Your COVID-19 mask may have allergens that cause this skin illness
Throughout the course of the COVID-19 pandemic, those able to wear a face mask have been encouraged to do so to prevent transmission of...
This new drug can lower risk for heart failure death
In a new study, researchers found that omecamtiv mecarbil, a new, investigational heart drug, reduced the risk of heart failure-related events in patients with...